InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: 1234jklm post# 75007

Thursday, 09/14/2017 9:24:17 AM

Thursday, September 14, 2017 9:24:17 AM

Post# of 144814
I owned AZN, CARA, and ZYNE when their FDA trials missed end points. AZN lost 20%, CARA and ZYNE lost 50%.

IMO because of poorly designed trials. These were safe, effective drugs that had bad end point targets and the stocks got smashed.

KW has said repeatedly that they have ONE chance to get the pancreatic cancer IND right. This can't be understated enough. PMCB should only file that IND when it is absolutely perfect.

Know What You Own. My posts should not be construed as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News